Eurovet

Eurovet Animal Health is a prominent veterinary pharmaceutical company based in the Netherlands, specializing in the development and manufacture of high-quality animal health products. The company offers a comprehensive portfolio of medicines for both companion animals and livestock, with key strengths in endocrinology, dermatology, and anti-infectives. In 2012, Eurovet was acquired by Dechra Pharmaceuticals for approximately €135 million, a strategic move that significantly expanded Dechra's presence in the European market. Today, Eurovet operates as a core part of Dechra's manufacturing and R&D infrastructure, continuing to produce essential veterinary treatments such as Forthyron and Isathal. The company's facilities in Bladel serve as a major hub for the production of sterile and non-sterile pharmaceuticals for global distribution.